Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B

Journal of Medical Virology

Volumn 53, Issue 3, 1997, Pages 282-287

  Heijtink, Rudolf A ^a   Kruining, Johannes ^a   Honkoop, Pieter ^a   Kuhns, Mary C ^b   Hop, Wim C J ^a   Osterhaus, Albert D M E ^a   Schalm, Solko W ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Antiviral therapy; HBeAg; Hepatitis B virus; Interferon; Lamivudine; Prognosis; Quantitation

Indexed keywords

HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; SEROCONVERSION; VIRUS DETECTION;

ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERONS; LAMIVUDINE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0031419744     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199711)53:3<282::AID-JMV18>3.0.CO;2-J     Document Type: Article

References (6)

1. Berk L, Schalm SW, De Man RA, Heijtink RA, Berthelot P, Brechot C, Boboc B, Degos F, Marcelling P, Benhamou J-P, Hess G, Rossol S, Meyer zum Buschenfelde K-H, Chamuleau RAFM, Jansen PLM, Reesink HW, Meyer B, Berlinger C, Stalder GC, Den Ouden-Muller JW, De Jong M (1992): Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B: A multicentre randomized controlled trial. Journal of Hepatology 14:305-309.
2. Brook MG, Karayiannis P, Thomas HC (1989): Which patient with chronic type B virus infection will respond to alfa-interferon therapy? A statistical analysis of predictive factors. Hepatology 10:761-763.
3. Cox DR (1972): Regression models and life tables. Journal of the Royal Statistical Society B 34:181-220.
4. Janssen HLA, Berk L, Heijtink RA, Schalm SW, Hess G, Rossol S, Meyer zum Busschenfelde K-H, Chamuleau RAFM, Jansen PLM, Reesink HW, Meyer B, Beglinger C, Den Ouden-Muller JW, De Jong M, Mulder CJJ (1992): The antiviral effect of prolonged intermittent lymphoblastoid alpha-interferon treatment in chronic hepatitis B. Gut 33:1094-1098.
5. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, and the Hepatitis Interventional Therapy Group (1990): A randomized controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. New England Journal of Medicine 323:295-301.
6. Perrillo RP, Mimms L, Schechtman K, Robbins D, Campbell C (1993): Monitoring of antiviral therapy with quantitative evaluation of HBeAg: A comparison with HBV DNA testing. Hepatology 18: 1306-1312.